FDA Reviews Two New Drugs to Reduce Prostate Cancer

Health regulators say two drugs from GlaxoSmithKline and Merck reduce the risk of prostate tumors in men, though scientists complain the companies only studied a small number of African Americans, who are at high risk for prostate cancer.
ABC News